Keyphrases
Cardiology
95%
Antiplatelet Therapy
74%
Popliteal Artery Aneurysm
66%
Stent-graft
66%
Endovascular Repair
66%
Acute Coronary Syndrome
66%
Subclavian Steal Syndrome
66%
Chronic Total Occlusion
66%
Left Subclavian Artery
66%
Endovascular Treatment
66%
No-reflow
66%
Coronary No-reflow
66%
Graft Rupture
66%
Spontaneous Rupture
66%
Saphenous Vein Graft
66%
Deglutition
66%
Reflex Syncope
66%
Myocarditis
66%
Nivolumab
66%
Immune Checkpoint Inhibitors
66%
Superlatives
66%
Cardiac Drugs
66%
Syncope
66%
News Articles
66%
Trial Reporting
66%
Randomized Controlled Trial
66%
AMSTAR
66%
Telemetry
50%
Chest Pain
48%
Meta-analysis
44%
Systematic Meta-analysis
44%
Characteristic 2
44%
Drug Class
40%
Percutaneous Coronary Intervention
38%
Covered Stent
33%
Popliteal Aneurysm
33%
Treatment Standards
33%
Surgical Resection
33%
Acute Dyspnea
33%
Older Female Patient
33%
Syncopal Episode
33%
Cardiotoxicity
33%
Coronary Vessels
33%
Overall Survival
33%
Disease Outcome
33%
Dizziness
33%
Data Extraction
31%
Past Medical History
24%
Echocardiogram
24%
Implementing Change
22%
Medicine and Dentistry
Percutaneous Coronary Intervention
100%
Antiplatelet
80%
Cardiology
76%
Popliteal Artery Aneurysm
66%
Stent-Graft
66%
No Reflow Phenomenon
66%
Acute Coronary Syndrome
66%
Chronic Total Occlusion
66%
Left Subclavian Artery
66%
Coronary Subclavian Steal Syndrome
66%
Randomized Controlled Trial
66%
Rupture
66%
Saphenous Vein Graft
66%
Swallowing
66%
Faintness
66%
Cross Sectional Study
66%
Systematic Review
66%
Thorax Pain
60%
Angiography
53%
Dizziness
44%
Intravascular Ultrasound
40%
Vasodilator Agent
40%
Blood Clot Lysis
40%
Drug Therapy
40%
Myocardial Infarction
40%
Blood Flow
40%
Aneurysm
33%
Bypass Surgery
33%
Surgery
33%
Dyspnea
33%
Coronary Vessel
33%
Coronary Artery Bypass Graft
33%
Exercise
33%
Minimally Invasive Procedure
33%
Drug-Eluting Stent
26%
Right Coronary Artery
26%
Troponin
24%
Medical History
24%
Echocardiography
24%
Electrocardiogram
24%
Clinical Decision Making
19%
Prevalence
19%
Meta-Analysis
19%
Medicine
19%
Coronary Circulation
13%
ST Elevation
13%
Embolization
13%
Beta Adrenergic Receptor Blocking Agent
13%
Vasospasm
13%
Coronary Microvascular Dysfunction
13%